• Thibault Passeri, Paolo di Russo, Pierre-Olivier Champagne, Anne-Laure Bernat, Jérome Cartailler, Jean Pierre Guichard, Hamid Mammar, Lorenzo Giammattei, Homa Adle-Biassette, Bernard George, Emmanuel Mandonnet, and Sébastien Froelich.
• Department of Neurosurgery, Lariboisière Hospital, Assistance Publique - Hôpitaux de Paris, University of Paris, Paris, France.
• Neurosurgery. 2021 Jul 15; 89 (2): 291-299.

BackgroundCurrently, different postoperative predictors of chordoma recurrence have been identified. Tumor growth rate (TGR) is an image-based calculation that provides quantitative information of tumor's volume changing over time and has been shown to predict progression-free survival (PFS) in other tumor types.ObjectiveTo explore the usefulness of TGR as a new preoperative radiological marker for chordoma recurrence.MethodsA retrospective single-institution study was carried out including patients reflecting these criteria: confirmed diagnosis of chordoma on pathological analysis, no history of previous radiation, and at least 2 preoperative thin-slice magnetic resonance images available to measure TGR. TGR was calculated for all patients, showing the percentage change in tumor size over 1 mo.ResultsA total of 32 patients were retained for analysis. Patients with a TGR ≥ 10.12%/m had a statistically significantly lower mean PFS (P < .0001). TGR ≥ 10.12%/m (odds ratio = 26, P = .001) was observed more frequently in recurrent chordoma. In a subgroup analysis, we found that the association of Ki-67 labeling index ≥ 6% and TGR ≥ 10.12%/m was correlated with recurrence (P = .0008).ConclusionTGR may be considered as a preoperative radiological indicator of tumor proliferation and seems to preoperatively identify more aggressive tumors with a higher tendency to recur. Our findings suggest that the therapeutic strategy and clinical-radiological follow-up of patients with chordoma can be adapted also according to this new parameter.© Congress of Neurological Surgeons 2021.

17 keywords...

hide…